Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease M Binks, JR Passweg, D Furst, P McSweeney, K Sullivan, C Besenthal, ... Annals of the rheumatic diseases 60 (6), 577-584, 2001 | 350 | 2001 |
Extended reports-Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: Procedure related mortality and impact on skin disease M Binks, JR Passweg, D Furst, P McSweeney, K Sullivan, C Besenthal, ... Annals of the Rheumatic Diseases 60 (6), 577-584, 2001 | 350* | 2001 |
Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial F Moniche, A Gonzalez, JR Gonzalez-Marcos, M Carmona, P Pinero, ... Stroke 43 (8), 2242-2244, 2012 | 249 | 2012 |
Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. JA Snowden, J Passweg, JJ Moore, S Milliken, P Cannell, J Van Laar, ... The Journal of Rheumatology 31 (3), 482-488, 2004 | 212 | 2004 |
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled … M Aguilar-Guisado, I Espigado, A Martín-Peña, C Gudiol, ... The Lancet Haematology 4 (12), e573-e583, 2017 | 194 | 2017 |
The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from … A Urbano-Ispizua, C Rozman, P Pimentel, C Solano, J de la Rubia, ... Blood, The Journal of the American Society of Hematology 97 (2), 383-387, 2001 | 156 | 2001 |
Comparable survival between HIV+ and HIV− non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation JL Díez-Martín, P Balsalobre, A Re, M Michieli, JM Ribera, C Canals, ... Blood, The Journal of the American Society of Hematology 113 (23), 6011-6014, 2009 | 147 | 2009 |
Risk factors and outcome of COVID-19 in patients with hematological malignancies JL Piñana, R Martino, I García-García, R Parody, MD Morales, G Benzo, ... Experimental Hematology & Oncology 9 (1), 1-16, 2020 | 137 | 2020 |
Autologous stem-cell transplantation in patients with HIV-related lymphoma P Balsalobre, JL Díez-Martín, A Re, M Michieli, JM Ribera, C Canals, ... J Clin Oncol 27 (13), 2192-2198, 2009 | 135 | 2009 |
Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients P Ljungman, R de la Camara, L Perez-Bercoff, M Abecasis, ... Haematologica 96 (8), 1231-1235, 2011 | 131 | 2011 |
Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors J De La Rubia, C Arbona, F De Arriba, C Del Cañizo, S Brunet, C Zamora, ... Transfusion 42 (1), 4-9, 2002 | 118 | 2002 |
Haematopoetic stem cell transplantation for refractory autoimmune cytopenia JR Passweg, M Rabusin, M Musso, Y Beguin, S Cesaro, G Ehninger, ... British journal of haematology 125 (6), 749-755, 2004 | 108 | 2004 |
CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. A Pérez-García, R De la Camara, J Roman-Gomez, A Jimenez-Velasco, ... Blood, The Journal of the American Society of Hematology 110 (1), 461-467, 2007 | 101 | 2007 |
Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings A Urbano-Ispizua, C Rozman, P Pimentel, C Solano, J de la Rubia, ... Blood, The Journal of the American Society of Hematology 100 (2), 724-727, 2002 | 98 | 2002 |
Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study M Aguilar‐Guisado, M Jiménez‐Jambrina, I Espigado, M Rovira, ... Clinical transplantation 25 (6), E629-E638, 2011 | 93 | 2011 |
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study VE Gómez, V García-Gutiérrez, LL Corral, IG Cadenas, AP Martínez, ... Bone Marrow Transplantation 55 (3), 641-648, 2020 | 85 | 2020 |
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multi-center survey study V Escamilla Gomez, V García Gutiérrez, T Caballero-Velázquez, ... Blood 130 (Supplement 1), 1983-1983, 2017 | 85 | 2017 |
Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease M Jurado, C Vallejo, JA Pérez-Simón, S Brunet, C Ferra, P Balsalobre, ... Biology of Blood and Marrow Transplantation 13 (6), 701-706, 2007 | 79 | 2007 |
Donor age‐related differences in PBPC mobilization with rHuG–CSF J De la Rubia, MA Díaz, A Verdeguer, MJ Pascual, C Arbona, R Arrieta, ... Transfusion 41 (2), 201-205, 2001 | 79 | 2001 |
Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study M Jurado, C De La Mata, A Ruiz-García, E López-Fernández, O Espinosa, ... Cytotherapy 19 (8), 927-936, 2017 | 77 | 2017 |